Sensyne Health (SENS) Share Price, News & Analysis

Company Overview

Sensyne Health plc is a healthcare technology company that creates value from accelerating the discovery and development of new medicines and improving patient care through the analysis of real-world evidence from large databases of anonymised patient data in collaboration with NHS Trusts. These anonymised patient data are ethically sourced in that any analysis of anonymised patient data (and hence the Company’s access to it) must be pre-approved for each programme on a case-by-case basis by the relevant NHS Trusts. This is to ensure that the purpose of the anonymisation and the proposed analysis are subject to appropriate ethical oversight and information governance, including conformance with NHS principles, UK data protection law and applicable regulatory guidance. Sensyne Health is an early signatory to the Department of Health and Social Care’s ‘Initial Code of Conduct for data-driven health and care technology’.

Key Stats

• Today's Range: N/A
• 50-Day Range: 0.35 to 0.35
• 52-Week Range: N/A
• Volume: 4.45 million shs
• Average Volume: 3.45 million shs
• Market Capitalization: £583,000.00
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SENS Stock Analysis - Frequently Asked Questions

How do I buy shares of Sensyne Health?

Shares of SENS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of Sensyne Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Sensyne Health investors own include bluebird bio (BLUE), BP (BP), Green Plains Partners (GPP), Royal Dutch Shell (RDSB), Artemis Resources (ARV), Athene (ATH) and BELLUS Health (BLU).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Computer and Technology
• Industry: Health Information Services
• Sub-Industry: N/A
• Current Symbol: LON:SENS
• CUSIP: N/A
• CIK: N/A
• Web: www.sensynehealth.com
• Phone: 44 3300 581845
• Fax: N/A
• Employees: 70
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 5.83
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 6.02
• Current Ratio: 2.26
• Quick Ratio: 2.26

Sales & Book Value

• Annual Sales: £7.81 million
• Price / Sales: 0.07
• Cash Flow: GBX 4.90 per share
• Price / Cash Flow: 0.07
• Book Value: GBX 20.30 per share
• Price / Book: 0.02

Miscellaneous

• Outstanding Shares: 166,464,000
• Free Float: N/A
• Market Cap: £582,624.00
• Optionable: Not Optionable
• Beta: N/A